Recursion Appoints R
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
24 mai 2024 16h30 HE | Recursion Pharmaceuticals
SALT LAKE CITY, May 24, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Robert...
Recursion Announces
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
13 mai 2024 05h00 HE | Recursion Pharmaceuticals
SALT LAKE CITY, May 13, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the completion...
Recursion Pharmaceuticals
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
09 mai 2024 16h01 HE | Recursion Pharmaceuticals
On track to read out multiple Phase 2 clinical trials in the coming quarters, beginning in Q3 2024Performance benchmarking completed on BioHive-2, Recursion's next generation supercomputer, which will...
Recursion to Report
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
02 mai 2024 08h00 HE | Recursion Pharmaceuticals
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
Recursion to Partici
Recursion to Participate in Upcoming Investor Conferences
01 mai 2024 08h01 HE | Recursion Pharmaceuticals
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Altitude Lab Secures
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
30 avr. 2024 08h00 HE | Recursion Pharmaceuticals
SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- Altitude Lab and the Small Business Administration (SBA) are pleased to announce Horizon, a commercialization program to connect startups to...
Recursion to Partici
Recursion to Participate in Upcoming Investor Conference
02 avr. 2024 08h00 HE | Recursion Pharmaceuticals
SALT LAKE CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Recursion Publishes
Recursion Publishes Annual Environmental, Social and Governance Report
26 mars 2024 08h00 HE | Recursion Pharmaceuticals
SALT LAKE CITY, March 26, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...
Speakers at Recursion's Rare Disease Day Event
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
01 mars 2024 14h58 HE | Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, hosted its second annual Rare...
Recursion to Partici
Recursion to Participate in Upcoming Investor Conferences
01 mars 2024 07h59 HE | Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...